214 related articles for article (PubMed ID: 16529565)
1. Duloxetine in women awaiting surgery.
Drutz H
BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
6. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
Freeman RM
BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
Zinner NR
Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
[TBL] [Abstract][Full Text] [Related]
12. The use of Duloxetine in the treatment of male stress urinary incontinence.
Fink KG; Huber J; Würnschimmel E; Schmeller NT
Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence.
Cardozo L; Lange R; Voss S; Beardsworth A; Manning M; Viktrup L; Zhao YD
Curr Med Res Opin; 2010 Feb; 26(2):253-61. PubMed ID: 19929591
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence.
Bent AE; Gousse AE; Hendrix SL; Klutke CG; Monga AK; Yuen CK; Muram D; Yalcin I; Bump RC
Neurourol Urodyn; 2008; 27(3):212-21. PubMed ID: 17580357
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
Cardozo L; Drutz HP; Baygani SK; Bump RC
Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial.
Lin AT; Sun MJ; Tai HL; Chuang YC; Huang ST; Wang N; Zhao YD; Beyrer J; Wulster-Radcliffe M; Levine L; Chang C; Viktrup L
BMC Urol; 2008 Jan; 8():2. PubMed ID: 18221532
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
19. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
20. Update on duloxetine for the management of stress urinary incontinence.
Basu M; Duckett JR
Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
